• Annals of surgery · Sep 2015

    Multicenter Study Comparative Study Observational Study

    Defining Long-term Outcomes With Living Donor Liver Transplantation in North America.

    • Kim M Olthoff, Abigail R Smith, Michael Abecassis, Talia Baker, Jean C Emond, Carl L Berg, Charlotte A Beil, James R Burton, Robert A Fisher, Chris E Freise, Brenda W Gillespie, David R Grant, Abhinav Humar, Igal Kam, Robert M Merion, Elizabeth A Pomfret, Benjamin Samstein, and Abraham Shaked.
    • *Department of Surgery, University of Pennsylvania, Philadelphia, PA †Department of Biostatistics, University of Michigan, Ann Arbor, MI ‡Arbor Research Collaborative for Health, Ann Arbor, MI §Northwestern University Comprehensive Transplant Center, Chicago, IL ¶Center for Liver Disease and Transplantation, Columbia University, New York, NY ∥Duke University Health System, Durham, NC **Department of Medicine, University of Colorado, Aurora, CO ††Division of Transplantation, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA ‡‡Department of Surgery, University of California San Francisco, San Francisco, CA §§Department of General Surgery, Toronto Hospital, General Division, Toronto, Ontario, Canada ¶¶Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA ∥∥Department of Surgery, University of Colorado, Denver, CO ***Department of Surgery, University of Michigan, Ann Arbor, MI; and †††Department of Transplantation, Lahey Clinic Medical Center, Tufts University School of Medicine, Boston, MA.
    • Ann. Surg. 2015 Sep 1;262(3):465-75; discussion 473-5.

    ObjectivesTo compare long-term survival of living donor liver transplant (LDLT) at experienced transplant centers with outcomes of deceased donor liver transplant and identify key variables impacting patient and graft survival.BackgroundThe Adult-to-Adult Living Donor Liver Transplantation Cohort Study is a prospective multicenter National Institutes of Health study comparing outcomes of LDLT and deceased donor liver transplant and associated risks.MethodsMortality and graft failure for 1427 liver recipients (963 LDLT) enrolled in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study who received transplant between January 1, 1998, and January 31, 2014, at 12 North American centers with median follow-up 6.7 years were analyzed using Kaplan-Meier and multivariable Cox models.ResultsSurvival probability at 10 years was 70% for LDLT and 64% for deceased donor liver transplant. Unadjusted survival was higher with LDLT (hazard ratio = 0.76, P = 0.02) but attenuated after adjustment (hazard ratio = 0.98, P = 0.90) as LDLT recipients had lower mean model for end-stage liver disease (15.5 vs 20.4) and fewer received transplant from intensive care unit, were inpatient, on dialysis, were ventilated, or with ascites. Posttransplant intensive care unit days were less for LDLT recipients. For all recipients, female sex and primary sclerosing cholangitis were associated with improved survival, whereas dialysis and older recipient/donor age were associated with worse survival. Higher model for end-stage liver disease score was associated with increased graft failure. Era of transplantation and type of donated lobe did not impact survival in LDLT.ConclusionsLDLT provides significant long-term transplant benefit, resulting in transplantation at a lower model for end-stage liver disease score, decreased death on waitlist, and excellent posttransplant outcomes. Recipient diagnosis, disease severity, renal failure, and ages of recipient and donor should be considered in decision making regarding timing of transplant and donor options.Clinical Trials ID: NCT00096733.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.